Clinical Trial Update: A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and clinical effects of interferon gamma-1b in idiopathic pulmonary fibrosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: InterMune | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED